Skip to content

SANGAMO THERAPEUTICS, INC.: filings

Every SANGAMO THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 60 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-14fiscal Q1 202642900001628280-26-035067
10-K2026-03-30fiscal FY 202546930001628280-26-022029
10-Q2025-11-06fiscal Q3 2025421220001001233-25-000024
10-Q2025-08-07fiscal Q2 2025401160001628280-25-038860
10-Q2025-05-12fiscal Q1 202541880001628280-25-024650
10-K2025-03-17fiscal FY 202448990001628280-25-013088
10-Q2024-11-12fiscal Q3 2024401160001628280-24-047102
10-Q2024-08-06fiscal Q2 2024381100001628280-24-035165
10-Q2024-05-09fiscal Q1 202436780001628280-24-022194
10-K2024-03-13fiscal FY 2023501280001628280-24-010788
10-Q2023-11-01fiscal Q3 2023421180001628280-23-035989
10-Q2023-08-08fiscal Q2 2023421180001628280-23-028200
10-Q2023-05-08fiscal Q1 202343940001628280-23-016486
10-K2023-02-23fiscal FY 2022481230001628280-23-004666
10-Q2022-11-03fiscal Q3 2022421180001628280-22-028168
10-Q2022-08-04fiscal Q2 2022421180001628280-22-021140
10-Q2022-05-05fiscal Q1 202242900001628280-22-012629
10-K2022-02-24fiscal FY 2021491230001628280-22-003819
10-Q2021-11-04fiscal Q3 2021441210001628280-21-021629
10-Q2021-08-05fiscal Q2 2021451230001628280-21-015869
10-Q2021-05-04fiscal Q1 202141870001628280-21-008878
10-K2021-02-24fiscal FY 2020461460001628280-21-003069
10-Q2020-11-04fiscal Q3 2020391030001628280-20-015504
10-Q2020-08-05fiscal Q2 202038990001628280-20-011806
10-Q2020-05-11fiscal Q1 202038810001628280-20-007462
10-K2020-02-28fiscal FY 2019441420001628280-20-002582
10-Q2019-11-06fiscal Q3 201938970001628280-19-013510
10-Q2019-08-07fiscal Q2 201938990001628280-19-010300
10-Q2019-05-08fiscal Q1 201936710001564590-19-017255
10-K2019-03-01fiscal FY 2018421310001564590-19-005808
10-Q2018-11-08fiscal Q3 201833800001564590-18-028636
10-Q2018-08-08fiscal Q2 201830740001564590-18-020536
10-Q2018-05-10fiscal Q1 201826540001564590-18-012641
10-K2018-03-01fiscal FY 2017321040001564590-18-004163
10-Q2017-11-09fiscal Q3 201728730001564590-17-023266
10-Q2017-08-09fiscal Q2 201728730001564590-17-017005
10-Q2017-05-10fiscal Q1 201725520001564590-17-010305
10-K2017-02-28fiscal FY 2016321030001564590-17-002900
10-Q2016-10-27fiscal Q3 201628750001564590-16-026384
10-Q2016-08-04fiscal Q2 201628740001564590-16-022708
10-Q2016-05-05fiscal Q1 201628550001564590-16-018000
10-K2016-02-18fiscal FY 2015311010001564590-16-012882
10-Q2015-10-30fiscal Q3 201528730001564590-15-009009
10-Q2015-08-06fiscal Q2 201528720001564590-15-006479
10-Q2015-04-28fiscal Q1 201528560001564590-15-002929
10-K2015-02-25fiscal FY 2014301000001564590-15-000950
10-Q2014-10-28fiscal Q3 201425660001564590-14-004591
10-Q2014-07-29fiscal Q2 201425660001193125-14-284673
10-Q2014-05-07fiscal Q1 201427560001193125-14-187386
10-K2014-02-24fiscal FY 2013321070001193125-14-065170
10-Q2013-11-04fiscal Q3 201327700001193125-13-425338
10-Q2013-08-02fiscal Q2 201327700001193125-13-317308
10-Q2013-05-09fiscal Q1 201327560001193125-13-210364
10-K2013-02-26fiscal FY 2012311060001193125-13-076887
10-Q2012-11-02fiscal Q3 201228740001193125-12-448965
10-Q2012-08-03fiscal Q2 201228740001193125-12-334668
10-Q2012-05-07fiscal Q1 201228580001193125-12-215404
10-K2012-02-23fiscal FY 201127720001193125-12-073470
10-Q2011-11-04fiscal Q3 201126680001193125-11-297311
10-Q2011-08-05fiscal Q2 201126680001193125-11-212305

Inspect the source

Entity
SANGAMO THERAPEUTICS, INC. / CIK 0001001233
Captured
2026-09-20T05:11:11.650Z
SEC response SHA-256
f678a4cd3364c095e387026eb9f115ac294a4697b3c5aebe6c86663002f694af

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001001233.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))